Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Clin Endocrinol (Oxf). 2013 Jan;78(1):67-72. doi: 10.1111/j.1365-2265.2012.04362.x.
Recent studies have shown that an elevated 1-h postload plasma glucose (1hPG) is able to identify subjects with normal glucose tolerance (NGT) at high risk for future type 2 diabetes and atherosclerotic cardiovascular disease. However, clinical studies about the characteristics of coronary heart disease (CHD) patients with elevated 1hPG are lacking. The aim of this study was to analyse the 1hPG level in CHD patients with NGT.
A total of 204 CHD patients with NGT were recruited. Subjects underwent an oral glucose tolerance test, echocardiography and coronary angiography. Demographic data were recorded and blood samples obtained. According to the 1hPG cut-off point of 8.6 mm, patients were divided into two groups: 1hPG ≥ 8.6 mm (n = 65) and 1hPG < 8.6 mm (n = 139).
Compared with the 1hPG < 8.6 mm group, subjects with 1hPG ≥ 8.6 mm had a worse metabolic profile, exhibiting significantly higher body mass index, systolic blood pressure, triglyceride level and lower HDL-cholesterol level. Plasma high-sensitivity CRP (hsCRP) levels were higher in the 1hPG ≥ 8.6 mm group than in the 1hPG < 8.6 mm group. Coronary angiography revealed that single-vessel changes were more frequent in the 1hPG < 8.6 mm group, but there were no significant differences in the Gensini score.
Patients with CHD with 1hPG ≥ 8.6 mm have a worse metabolic profile, higher levels of hsCRP and multi-vessel coronary atherosclerosis. These findings suggest that, in patients with CHD, elevated 1hPG increases coronary risk factors and may be a marker for early-stage glucose intolerance.
最近的研究表明,1 小时餐后血糖(1hPG)升高能够识别出糖耐量正常(NGT)的人群,这些人群未来发生 2 型糖尿病和动脉粥样硬化性心血管疾病的风险较高。然而,关于 1hPG 升高的冠心病(CHD)患者的临床研究尚少。本研究旨在分析 CHD 合并 NGT 患者的 1hPG 水平。
共纳入 204 例 CHD 合并 NGT 的患者。患者行口服葡萄糖耐量试验、超声心动图和冠状动脉造影。记录患者的人口统计学资料并采集血样。根据 1hPG 截断值 8.6mmol/L,将患者分为两组:1hPG≥8.6mmol/L(n=65)和 1hPG<8.6mmol/L(n=139)。
与 1hPG<8.6mmol/L 组相比,1hPG≥8.6mmol/L 组患者的代谢指标更差,表现为体重指数、收缩压、甘油三酯水平更高,而高密度脂蛋白胆固醇水平更低。1hPG≥8.6mmol/L 组的血浆高敏 C 反应蛋白(hsCRP)水平高于 1hPG<8.6mmol/L 组。冠状动脉造影显示,1hPG<8.6mmol/L 组单支血管病变更为常见,但 Gensini 评分无显著差异。
1hPG 升高的 CHD 患者代谢指标更差,hsCRP 水平更高,多支血管发生动脉粥样硬化。这些发现提示,在 CHD 患者中,1hPG 升高增加了冠状动脉风险因素,可能是早期糖不耐受的标志物。